Literature DB >> 23690428

Complete remission after treatment with single-agent ofatumumab in a patient with high-risk leukemic mantle-cell lymphoma.

Friederike Hunstig1, Jakob Hammersen, Christa Kunert, Iver Petersen, Hartmut Merz, Anita Glaser, Ulf Teichgräber, Andreas Hochhaus, Paul La Rosée.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23690428     DOI： 10.1200/JCO.2012.45.9438

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.

Authors:  Matthew J Barth; Cory Mavis; Myron S Czuczman; Francisco J Hernandez-Ilizaliturri
Journal:  Clin Cancer Res       Date:  2015-05-11       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.